Atadja Peter 4
4 · Onconova Therapeutics, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Atadja Peter
Director
Transactions
- Award
Stock Option (right to purchase)
2022-12-15+100,000→ 100,000 totalExercise: $0.71Exp: 2032-12-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary.